top of page
Search

Preclinical Research with a First-in-Class ALS Therapy Formulation

Updated: Aug 27, 2024

Preclinical Research with a ALS Therapy Formulation | Canurta Therapeutics

We are pleased to present our research poster detailing our preclinical study on a first-in-class ALS therapy formulation. This work was showcased at the ALS Drug Development Summit in Boston.


View our research poster below.


Preclinical Research with a First-in-Class ALS Therapy Formulation

bottom of page